Target intelligence / Profile preview

Transcription regulator protein BACH2 (BACH2)

Target
BACH2
Molecular classification
Transcription factor, basic leucine zipper (bZip) family, BTB/POZ domain-containing protein
01

Overview

Transcription regulator protein BACH2 is a member of the basic leucine zipper (bZip) transcription factor family, characterized by a BTB/POZ domain and a bZip_Maf domain. It plays crucial roles in adaptive immunity by repressing terminal differentiation of lymphocytes, promoting long-lived memory T cells, supporting regulatory T cell and B cell development, and preventing excessive inflammatory or autoimmune responses. BACH2 controls gene expression by binding to Maf recognition elements and interacting with AP-1 family transcription factors, acting as a checkpoint for immune cell fate. Loss or mutation of BACH2 has been linked to immunodeficiencies (notably IMD60), autoimmunity, and cancers of the lymphoid lineage[1][3][4][5].

Other names
BTB and CNC homolog 2BTBD25IMD60basic leucine zipper transcription factor 2BTB domain and CNC homolog 2broad complex-tramtrack-bric a brac and Cap'n'collar homology 2
02

Mechanism of action

Transcriptional repression or activation via binding to Maf recognition elements (MAREs); impacts immune cell differentiation and function by regulating gene expression in T and B lymphocytes[1][5].

03

Biological functions

Regulation of gene expressionadaptive immunity (T cell and B cell differentiation)apoptosis in response to oxidative stressregulatory T cell generationB cell maturationrepression of terminal differentiation in T cells
04

Disease associations

CancerAutoimmunityImmunodeficiency (notably Immunodeficiency 60/IMD60)InflammationOther immune-related disorders
05

Safety considerations

Modulating BACH2 may risk immune imbalance, leading to unwanted inflammation, reduced immune memory, or increased risk of infections and immune-related toxicity[1][3].
06

Interacting drugs

No well-characterized marketed drugs directly target BACH2 as of the latest knowledge, but some experimental small molecules are in screening stages[3].
07

Biomarkers

Loss or reduced expression of BACH2 in immune cells can be a biomarker for immunodeficiency syndromes, risk of autoimmunity, and some lymphoid cancers[3][4].

Beyond the preview

Go deeper on Transcription regulator protein BACH2 (BACH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription regulator protein BACH2 (BACH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call